KRO
KRONOS WORLDWIDE INC
NYSE · Basic Materials · Chemicals - Specialty · US
$7.32
−1.48%Year over year
Reported trailing growth
- Revenue
- +2.7%
- EBITDA
- -88.7%
- EBIT
- —
- EPS
- —
- Free cash flow
- +239.6%
- Operating cash flow
- +2239.0%
Forward estimates
Based on analyst estimates
- Revenue
- -20.3%
- EBITDA
- +468.6%
- EPS
- +145.7%
Three-year CAGR
- Revenue
- -1.2%
- EBITDA
- -53.8%
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026